Location permission needed for a better experience.
How can we help you?
EN
Hızlı Randevu
Hastane
Randevusu
Görüntülü Görüşme Randevusu

18 yaş ve altı hastalar kabul edilmektedir. Profesör veya doçent doktor tercihinizde öğretim üyesi farkı oluşabilir. Ayrıca kurumlara ait uygulama esasları farklılık gösterebilir.

Education
  • 2014 İstanbul Bilim University Florence Nightingale Hospital / Çocuk Kardiyolojisi / Prof. Dr.
  • 2013 Çocuk Kardiyolojisi / Associate Professor Dr.
  • 2011 Gazi University Faculty of Medicine Çocuk Kardiyolojisi
  • 2003 İzmir Dr. Behçet Uz Çocuk Hastalıkları Eğitim ve Araştırma Hospital Çocuk Sağlığı ve Hastalıkları
  • 1995 Uludağ University Faculty of Medicine
Experience
  • 2021 Acıbadem Healthcare Services
  • 2013 - 2020 Florence Nightingale Hospital / Çocuk Kardiyolojisi Öğretim Görevlisi
  • 2011 - 2012 Siyami Ersek Kalp ve Damar Cerrahisi Hospital / Çocuk Kardiyolojisi
  • 2007 - 2008 Acıbadem İzmit Hospital / Çocuk Sağlığı ve Hastalıkları Uzmanı
  • 2004 - 2006 Sani Konukoğlu Hospital / Çocuk Hastalıkları
  • 2003 - 2004 Moris Şinasi Hospital / Çocuk Hastalıkları
Memberships
  • Türk Milli Pediyatri Association
  • Türk Pediyatrik Kardiyoloji ve Kalp Cerrahisi Association
  • İstanbul Tabip Odası
PUBLICATIONS
  • Pulmonary artery banding and venous bidirectional cava-pulmonary shunt for two-stage arterial switch procedure in late referral of patients with transposition of the great arteries and intact ventricular septum: midterm results Cardiol Young. 2019 May;29(5):649-654. doi: 10.1017/S104795111900043X.PMID: 31230611 Cevik A, Karaci AR, Polat B, Erturk M, Yalcin Y, Yazicioglu V, Salihoglu E.
  • Coronary sinus ostial atresia: A rare associated anomaly that should be remembered in patients undergoing univentricular palliation. Anatol J Cardiol. 2018 Nov;20(5):303-304. doi: 10.14744/AnatolJCardiol.2018.84453. Çevik A, Ertürk M, Turgut Balcı Ş, Yalçın K, Karacı AR.
  • Missing atrioventricular echogenic mass during paediatric HeartWare® implantation Anaesthesiol Intensive Ther. 2017;49(2):174. doi: 10.5603/AIT.a2017.0018. Epub 2017 Apr 18.PMID: 28417446 Saracoglu KT, Saracoglu A, Cevik A, Kafali IH.
  • Serum levels of soluble icam-1 in children with pulmonary artery hypertension Tex Heart Inst J. 2014 Apr 1;41(2):159-64. doi: 10.14503/THIJ-12-3012 Oguz MM, Oguz AD, Sanli C, Cevik A.
  • Evaluation of pulmonary vascular resistance and vasoreactivity testing with oxygen in children with congenital heart disease and pulmonary arterial hypertension Anadolu Kardiyol Derg. 2014 Mar;14(2):196-8. doi: 10.5152/akd.2014.4393. Epub 2014 Feb 11. Cevik A, Kula S, Olguntürk R, Tunaoğlu S, Oğuz D, Saylan B, Sanlı C.
.
.
.

Contact Us

Fill out the form below for your information requests

As Acıbadem Healthcare Group, you can report your requests, suggestions, thanks and complaints by filling out the form below or by contacting us at +90 538 685 39 52 so that we can provide you with a better and higher quality service.

See More
See More
Security Code

INFORMATION NOTICE ON THE PROCESSING OF PERSONAL DATA

Acıbadem Sağlık Hizmetleri ve Ticaret A.Ş. and its controlling and affiliated companies listed in Annex-1 (each referred to individually as the "Company" and collectively as the "Companies") process your general and/or special category personal data (including but not limited to health data) ("Personal Data") in the capacity of Data Controller under the Personal Data Protection Law No. 6698 ("Law") and related legislation. Processing of Personal Data is carried out in accordance with the framework outlined below and in compliance with the Fundamental Law on Health Services No. 3359, the Decree Law No. 663 on the Organization and Duties of the Ministry of Health and its Affiliated Institutions, the Regulation on the Provision of Remote Health Services, the Private Hospitals Regulation, the Ministry of Health regulations, and other relevant legislation.

I. Acquisition, Processing, and Purposes of Processing Personal Data

Your Personal Data is obtained through verbal, written, visual, or electronic channels (such as our website, mobile applications, and call center) for the purposes of protecting public health, preventive medicine, medical diagnosis, treatment and care services, and the planning and management of healthcare services and their financing, in alignment with the Company's fields of activity. The Personal Data processed by the Company, including but not limited to the following, is collected and processed proportionally and in connection with these purposes:

Your Personal Data may be processed under the conditions specified in Articles 5 and 6 of the Law for the following purposes:

II. Transfer of Personal Data

Your Personal Data may be shared with:

III. Method and Legal Basis for Collecting Personal Data

Your Personal Data is collected through verbal, written, visual, or electronic means for the lawful execution of the Company's activities and compliance with contractual and legal obligations. The legal basis for collection includes:

As per Article 6 - (3) of the Law, personal data related to health and sexual life may be processed without explicit consent by persons or institutions subject to confidentiality obligations for public health protection, preventive medicine, medical diagnosis, treatment, and care services, as well as the planning and management of healthcare financing.

IV. Your Rights Regarding the Protection of Personal Data

Under Article 11 of the Law, you have the right to:

V. Data Security

The Companies ensure the security of Personal Data by implementing necessary technical and administrative measures in accordance with information security standards and procedures.

VI. Complaints and Contact Information

To exercise your rights under the Law, you may submit a request through the methods specified in the "Acıbadem Sağlık Hizmetleri ve Ticaret A.Ş. Data Subject Application Form" available at https://www.acibadem.com.tr/acibademonline/images/Ac%C4%B1badem_Veri_Sahibi_Basvuru_Formu.pdf.

Requests can be submitted by mail, notarized document, or secure electronic means to:

ANNEX-1: List of Companies

 

TOP x""